Safety outcomes of darolutamide versus apalutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer (nmCRPC): Matching-adjusted indirect comparisons.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Jiang, S; Terasawa, E; Horton, VG; Ayyagari, R; Waldeck, AR; Halabi, S; Shore, ND

Published Date

  • May 20, 2020

Published In

Volume / Issue

  • 38 / 15

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X